Clinical Trials Directory

Trials / Completed

CompletedNCT01251770

Variation in Natremia Using Two Different Maintenance Intravenous Fluids in Postsurgical Hospitalized Children

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
78 (actual)
Sponsor
Hospital General de Niños Pedro de Elizalde · Academic / Other
Sex
All
Age
1 Month – 16 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to compare the blood sodium level after 12 hours following the initiation of therapy with either 0.3% NaCl/dextrose 5% or 0.45% NaCl/dextrose 5%, in postsurgical hospitalized children requiring maintenance IV fluid administration.

Detailed description

Background: Despite prescription of maintenance IV fluids in hospitalized children is widely used since 1957 (Holiday \& Segar), it is not always adequate for children with acute diseases, leading to hyponatremia. This mainly occurs due to a non-physiologic ADH secretion in this group of patients due to nausea, stress, pain, and surgical interventions, and the use of hypotonic maintenance IV fluids. 0.3% NaCl/dextrose 5%, is widely use as IV maintenance fluid in children after surgery. There is evidence suggesting that these IV fluids used in postsurgical hospitalized patients do not provide the adequate amount of sodium they require, leading to an increased risk of developing hyponatremia. Using 0.45% NaCl/dextrose 5% as IV maintenance fluid in these children would prevent hyponatremia, but this treatment has not been totally studied yet. Study procedures: Hospitalized children who fulfill inclusion criteria and not having any of the exclusion criteria will be considered for the enrolment after written informed consent. Venous blood samples will be taken at enrollment (baseline) for estimation of serum sodium. After randomization, one group will receive 0.3% NaCl/dextrose 5%, IV, at standard maintenance rate (100 ml/kg for the first 10 kg of body weight, 50 ml/kg for the next 10 kg, and 20 ml/kg for body weight exceeding 20 kg). The second group will receive 0.45% NaCl/dextrose 5%, IV, at the same rate. Serum sodium will be estimated in both groups after 12 hours of intravenous fluid therapy. Children who required oral fluids will be excluded from per-protocol analysis, and only analyzed for intention to treat.

Conditions

Interventions

TypeNameDescription
DRUG0.45% NaCl/dextrose 5%Subjects in this arm will receive 0.45% NaCl/dextrose 5% intravenous (IV) maintenance fluids.Total daily fluid infusion equal to: 80 ml/kg/day for those weighing up to 10 kg, and 1500 ml/m\^2 body surface.
DRUG0.3% NaCl/dextrose 5%Drug: 0.3% NaCl/dextrose 5% IV maintenance fluids. Total daily fluid infusion equal to: 80 ml/kg/day for those weighing up to 10 kg, and 1500 ml/m\^2 surface.

Timeline

Start date
2010-12-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2010-12-02
Last updated
2017-03-03
Results posted
2012-01-25

Locations

1 site across 1 country: Argentina

Source: ClinicalTrials.gov record NCT01251770. Inclusion in this directory is not an endorsement.